We serve Chemical Name:3-chloro-2,6-difluorophenylacetonitrile CAS:261762-55-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-chloro-2,6-difluorophenylacetonitrile
CAS.NO:261762-55-4
Synonyms:3-Chloro-2,6-difluorophenylacetonitrile;MFCD01631327
Molecular Formula:C8H4ClF2N
Molecular Weight:187.57400
HS Code:2926909090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:248.4ºC at 760mmHg
Density:1.379g/cm3
Index of Refraction:1.508
PSA:23.79000
Exact Mass:187.00000
LogP:2.68428
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:3276
Packing Group:III
Contact us for information like 3-Chloro-2,6-difluorophenylacetonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD01631327 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD01631327 Use and application,MFCD01631327 technical grade,usp/ep/jp grade.
Related News: Onyx Scientific, a small molecule API contract development and manufacturing organization (CDMO) has received a commercial API license for its UK facility. trideuterio(trideuteriomethylsulfanyl)methane manufacturers With the closing of AstraZeneca’s mega $39 billion buyout of Alexion Pharmaceuticals this week, the U.K. pharma has officially picked up Soliris and its successor, Ultomiris. 2-Methoxy-5-methylpyridine-3-boronic acid suppliers Novartis and GSK carried out a swap of its vaccine and cancer drugs back in 2015. GSK paid $5.25 billion to Novartis for its vaccine business, and Novartis sent $16 billion for GSK’s oncology programs. Tafinlar and Mekinist had already been granted FDA approval at the time of that deal, and as a part of that deal, Novartis agreed to divest its own BRAF and MEK inhibitors to avoid creating a monopoly. 7-iodo-1,2,3,4-tetrahydro-isoquinoline hydrochloride vendor & factory Onyx Scientific, a small molecule API contract development and manufacturing organization (CDMO) has received a commercial API license for its UK facility.,Onyx Scientific, a small molecule API contract development and manufacturing organization (CDMO) has received a commercial API license for its UK facility.
